Skip to main content

Baker Bros. Advisors LP

SEC CIK
0001263508
Latest filing
Aug 14, 2026

ABCL holding history

AbCellera Biologics Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABCL overviewAll 13F holders of ABCLFull Q2 2026 holdings

Shares (Q2 2026)
33,012,138
Value
$259.1M
% of portfolio
1.3%
Quarters held
22
Since Q1 2021
Holdings of ABCL by Baker Bros. Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202633,012,138$259.1M1.3%+2,736,200+9.0%AddedHolders
Q1 202630,275,938$105.7M0.6%+2,750,298+10.0%AddedHolders
Q4 202527,525,640$94.1M0.6%00.0%UnchangedHolders
Q3 202527,525,640$138.5M1.0%00.0%UnchangedHolders
Q2 202527,525,640$94.4M0.9%00.0%UnchangedHolders
Q1 202527,525,640$61.4M0.7%00.0%UnchangedHolders
Q4 202427,525,640$80.7M0.9%00.0%UnchangedHolders
Q3 202427,525,640$71.6M0.7%00.0%UnchangedHolders
Q2 202427,525,640$81.5M1.0%00.0%UnchangedHolders
Q1 202427,525,640$124.7M1.6%+4,615,887+20.1%AddedHolders
Q4 202322,909,753$130.8M1.5%+2,146,430+10.3%AddedHolders
Q3 202320,763,323$95.5M0.6%+4,313,143+26.2%AddedHolders
Q2 202316,450,180$106.3M0.6%+6,000,000+57.4%AddedHolders
Q1 202310,450,180$78.8M0.4%00.0%UnchangedHolders
Q4 202210,450,180$105.9M0.6%00.0%UnchangedHolders
Q3 202210,450,180$103.4M0.7%00.0%UnchangedHolders
Q2 202210,450,180$111.3M0.6%00.0%UnchangedHolders
Q1 202210,450,180$101.9M0.6%00.0%UnchangedHolders
Q4 202110,450,180$149.4M0.7%00.0%UnchangedHolders
Q3 202110,450,180$209.4M0.9%00.0%UnchangedHolders
Q2 202110,450,180$229.9M1.0%00.0%UnchangedHolders
Q1 202110,450,180$354.9M1.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.